Showing 6321-6330 of 19375 results for "".
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
https://reachmd.com/programs/frontlines-cidp/prioritizing-patient-centered-multidisciplinary-care-in-cidp/33070/Tailored, team-based care is essential for optimal outcomes in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). Ashley Baker sits down with Dr. Andrew Lee to learn more about the diagnostic complexities of the disease, the critical role of neuro-opthalmology, and the impoActive Aging: Preventing Heart Failure in Older Women with Exercise
https://reachmd.com/programs/heart-matters/active-aging-preventing-heart-failure-in-older-women-with-exercise/18106/How effective is low-intensity physical activity in older women at lowering the risk of heart failure? Tune in to find out.Next-Generation MS Care: The Promise of Cell-Based Therapeutics
https://reachmd.com/programs/neurofrontiers/ms-cell-based-therapeutics/54255/The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune system replacement via autologous stem cells, investigational mesenchymal repair strategies, and CAR T-cell approaches changing the treatment landscape. Hear from Dr. Mark Freedman as he dives into current and eComparing Photodynamic Therapy Approaches in Basal Cell Carcinoma
https://reachmd.com/programs/Audioabstracts/comparing-photodynamic-therapy-approaches-in-basal-cell-carcinoma/54696/Photodynamic therapy offers a nonsurgical treatment option for superficial basal cell carcinoma, but conventional protocols can be painful and time-intensive. Tune in to hear Ryan Quigley discuss findings from a randomized trial comparing conventional and simulated daylight photodynamic therapy, expRecognizing High-Risk Profiles for NSCLC
https://reachmd.com/programs/project-oncology/high-risk-profiles-nsclc/54577/Recognizing high-risk patient profiles is critical to avoiding delays in diagnosing non-small cell lung cancer (NSCLC). Join Dr. Jobelle Baldonado as she outlines the key risk factors that should lower the threshold for imaging and prompt timely evaluation. Dr. Baldonado is a thoracic surgeon at theComparing COVID-19 Vaccine Strategies: What Projections Reveal
https://reachmd.com/programs/clinicians-roundtable/comparing-covid-19-vaccine-strategies/48841/A recent comprehensive modeling study evaluated the potential impacts of varying COVID-19 vaccine recommendation strategies across different levels of viral evolution for the 2024–2025 season. Learn about the findings and their implications for vaccination policy with Dr. Sara Loo, an Assistant ScieATTRibute-CM Trial Updates: Long-Term Outcomes With Acoramidis
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/attr-cm-trial-acoramidis-long-term/49034/New data from the ATTRibute-CM trial offer insights into the long-term use of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM). To learn more about these results and their implications for patient care, Ryan Quigley sits down with Dr. Kevin Alexander, an Assistant ProfessoHow AI Is Transforming Biomarker Development in GI Oncology
https://reachmd.com/programs/project-oncology/ai-biomarker-development-gi-oncology/49169/From tumor detection to biomarker development, artificial intelligence (AI) is rapidly reshaping the landscape of gastrointestinal oncology. In this expert-led program, Dr. William Hall explains how AI is being applied to data to identify tumor features and treatment susceptibilities faster and moreNext Steps in COPD Care: Exploring Biologics for Frequent Exacerbators
https://reachmd.com/programs/deep-breaths-updates-chest/next-steps-in-copd-care-exploring-biologics-for-frequent-exacerbators/35933/Despite triple inhaled therapy, many patients with chronic obstructive pulmonary disease (COPD) continue to experience frequent and severe exacerbations, leading to hospitalizations, symptom burden, and higher mortality risk. In this expert-led discussion, Drs. Diego Maselli and Stephanie ChristensoThe Maternal Brain’s Role in Bone Health: Exploring CCN3’s Potential Power
https://reachmd.com/programs/frontlines-osteoporosis/the-maternal-brains-role-in-bone-health-exploring-cnn3s-potential-power/32343/Based on a recent study’s findings, CCN3 is a hormone released from the maternal brain that triggers skeletal stem cells to form new bone—a discovery that could transform osteoporosis treatment by targeting the condition at its root. Joining Ms. Ashley Baker to explore the key findings and clinical